Noble Financial restated their buy rating on shares of electroCore (NASDAQ:ECOR) in a research report released on Thursday morning, AnalystRatings.com reports. They currently have a $11.00 target price on the stock.
Other research analysts also recently issued research reports about the company. Cantor Fitzgerald downgraded electroCore from an overweight rating to a neutral rating and decreased their price objective for the stock from $19.00 to $9.00 in a report on Thursday, May 30th. BTIG Research reiterated a hold rating on shares of electroCore in a report on Wednesday, August 14th. Evercore ISI reiterated a buy rating and issued a $24.00 price objective on shares of electroCore in a report on Tuesday, August 13th. Zacks Investment Research downgraded electroCore from a buy rating to a hold rating in a report on Tuesday, August 13th. Finally, ValuEngine upgraded electroCore from a hold rating to a buy rating in a report on Thursday, August 1st. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $13.50.
ECOR opened at $1.64 on Thursday. The company has a market cap of $44.69 million, a P/E ratio of -1.38 and a beta of 2.84. The business’s 50-day moving average price is $1.54 and its 200-day moving average price is $4.55. The company has a current ratio of 6.63, a quick ratio of 10.07 and a debt-to-equity ratio of 0.04. electroCore has a 12 month low of $1.23 and a 12 month high of $17.99.
In other electroCore news, Director Thomas J. Errico bought 21,000 shares of the business’s stock in a transaction that occurred on Thursday, June 6th. The shares were bought at an average cost of $1.77 per share, with a total value of $37,170.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 43.78% of the stock is owned by company insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in electroCore by 4.8% in the second quarter. Vanguard Group Inc. now owns 664,936 shares of the company’s stock valued at $1,330,000 after buying an additional 30,671 shares during the last quarter. BlackRock Inc. lifted its stake in electroCore by 3.7% in the second quarter. BlackRock Inc. now owns 575,248 shares of the company’s stock valued at $1,150,000 after buying an additional 20,536 shares during the last quarter. Parametric Portfolio Associates LLC purchased a new stake in electroCore in the second quarter valued at approximately $99,000. Bronfman E.L. Rothschild L.P. purchased a new stake in electroCore in the second quarter valued at approximately $50,000. Finally, Rockefeller Capital Management L.P. purchased a new stake in electroCore in the second quarter valued at approximately $28,000. 15.36% of the stock is currently owned by institutional investors.
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Recommended Story: What is a Buy-Side Analyst?
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.